Skip to main content

T. Rowe Price Investment Management, Inc.

Position in RGEN — Repligen Corp

CIK 1897612 BALTIMORE, MD

Position in RGEN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$161,022,237
+$55,148,687 QoQ
Shares Held
1,366,680
+111.5% QoQ
Ownership
2.42%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority Sole 99.9328299236105.ToString("F0")% Shared 0.ToString("F0")% None 0.06717007638949864.ToString("F0")%

Common Shares in RGEN Over Time

Shares Held

Position Value (USD)

Position in Medical Instruments & Supplies

Healthcare · as of Mar 31, 2026

T. Rowe Price Investment Management, Inc. holds $3,661,498,498 across 8 Medical Instruments & Supplies names. RGEN ranks #5 (4.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 RGEN
Repligen Corp
This page
1,366,680 $161,022,237

All Filings in RGEN

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $161,022,237 1,366,680
2025-12-31 $105,873,550 646,122
2025-09-30 $76,469,666 572,078
2025-06-30 $69,600,436 559,579
2025-03-31 $33,190,299 260,848
2024-12-31 $22,894,664 159,057
2024-09-30 $4,123,802 27,710
2024-06-30 $64,368,252 510,616
2024-03-31 $78,444,454 426,514
2023-12-31 $72,524,487 403,362
2023-09-30 $45,044,670 283,282
2023-06-30 $39,575,981 279,768
2023-03-31 $9,525,977 56,581
2022-12-31 $8,071,177 47,671
2022-09-30 $8,112,715 43,358